Paul Bessette, MD
Paul Bessette, MD
Doctor
University of Sherbrooke
580 Rue Bowen Sud
Quebec,
QC
Canada
J1H 5N4
Papers:
8
A randomized double-blind phase III trial comparing vintafolide (EC145) and pegylated liposomal doxorubicin (PLD/Doxil®/Caelyx®) in combination versus PLD in participants with platinum-resistant ovarian cancer (PROCEED) (NCT01170650)